The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage - an observational study

Transfusion Medicine

Volumn 22, Issue 5, 2012, Pages 344-349

  Ahmed, S ^a   Harrity, C ^a   Johnson, S ^a   Varadkar, S ^a   Mcmorrow, S ^a   Fanning, R ^a   Flynn, C M ^a   O' Riordan, J M ^b   Byrne, B M ^a  

^a Tallaght and Coombe Women's and Infant's University Hospital   (Ireland)

^b National Blood Centre Ireland   (Ireland)

Author keywords

Fibrinogen; Haemorrhage; Obstetric

Indexed keywords

FIBRINOGEN CONCENTRATE; HAEMOCOMPLETTAN P; OCTAPLAS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; CRYOPRECIPITATE; DATA BASE; DRUG EFFECT; DRUG EFFICACY; ERYTHROCYTE CONCENTRATE; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HUMAN; HYPOFIBRINOGENEMIA; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OBSTETRIC HEMORRHAGE; OUTCOME ASSESSMENT; STATISTICAL SIGNIFICANCE;

ADULT; BLOOD LOSS, SURGICAL; COAGULANTS; DELIVERY, OBSTETRIC; FACTOR VIII; FEMALE; FIBRINOGEN; HEMORRHAGE; HUMANS; IRELAND; PREGNANCY; PROSPECTIVE STUDIES;

EID: 84866558767     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2012.01178.x     Document Type: Article

References (26)

1. American Society of Anesthesiologists taskforce on blood component therapy. (1996) Practice guidelines for blood component therapy. Anesthesiology, 84, 732-747.
2. Bell, S.F., Rayment, R., Collins, P.W. & Collis, R.E. (2010) The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. International Journal of Obstetric Anaesthesia, 19, 218-234.
3. Brace, V., Kernaghan, D. & Penney, G. (2007) Learning from adverse clinical outcomes: major obstetric haemorrhage in Scotland, 2003-2005. British Journal of Obstetrics and Gynaecology, 114, 1388-1396.
4. Callum, J.L., Karkouti, K. & Lin, Y. (2009) Cryoprecipitate: the current state of knowledge. Transfusion Medicine Reviews, 23, 177-188.
5. Charbit, B., Mandelbrot, L., Samain, E. et al. (2007) The decrease of fibrinogen is an early predictor of the severity of postpartum haemorrhage. Journal of Thrombosis and Haemostasis, 5, 266-273.
6. Dickneite, G., Pragst, I., Joch, C. & Bergman, G.E. (2009) Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P). Blood Coagulation & Fibrinolysis, 20, 535-540.
7. CWIUH (2010) Supplementary guidelines and related documents, clinical risk management department and department of transfusion medicine (version 11), 78-91. CWIUH.
8. Fenger-Eriksen, C., Lindberg-Larsen, M., Christensen, A.Q., Ingerslev, J. & Sorensen, B. (2008) Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. British Journal of Anaesthesia, 101, 769-773.
9. Foster, P.R. (1999) Assessment of the potential of plasma fractionation processes to remove causative agents of transmissible spongiform encephalopathy. Transfusion Medicine, 9, 3-14.
10. Foster, P.R., Welch, A.G., McLean, C., Griffin, B.D., Hardy, J.C., Bartley, A., MacDonald, S. & Bailey, A.C. (2000) Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma products. Vox Sanguinis, 78, 86-95.
11. Hiippala, S.T., Myllyla, G.J. & Vahtera, E.M. (1995) Haemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anaesthesia Analgesia, 81, 360-365.
12. Hogan, M.C., Foneman, K.J., Naghavi, M. et al. (2010) Maternal mortality for 181 countries; 1980-2008: a systematic analysis of progression towards millennium development goal 5. The Lancet, 375, 1609-1623.
13. Johnson, S.N., Khalid, S., Varadkar, S., Fleming, J., Fanning, R., Flynn, C.M. & Byrne, B. (2011) Quality of care in the management of major obstetric haemorrhage. Irish Medical Journal, 104, 119-121.
14. Knight, M., Callaghan, W.M., Berg, C. et al. (2009) Trends in PPH in high resourced countries: a review and recommendations from the International Post Partum Haemorrhage Collaborative Group. BMC Pregnancy and Childbirth, 9, 55.
15. Kratz, A. & Lewandrowski, K.B. (1998) Normal reference laboratory values. The New England Journal of Medicine, 339, 1063-1072.
16. Levy, J.H. (2006) Massive transfusion coagulopathy. Seminars in Hematology, 43, S59-S63.
17. Lynch, C.M., Sheridan, C., Breathnach, F.M., Said, S., Daly, S. & Byrne, B. (2008) Near miss maternal morbidity. Irish Medical Journal, 101, 134-136.
18. McClintock, C. & James, A.H. (2011) Obstetric hemorrhage. Journal of Thrombosis and Haemostasis, 9, 1441-1451.
19. O'Shaughnessy, D.F., Atterbury, C., Bolton, M.P., Murphy, M., Thomas, D., Yates, S. & Williamson, L.M. (2004) Guidelines for the use of FFP, cryoprecipitate and cryosupernatant. British Journal of Haematology, 126, 11-28.
20. Rossaint, R., Bouillon, B., Cerny, V. et al. (2010) Management of bleeding following major trauma: an updated European guideline. Critical Care, 14, R52.
21. Sher, G. (1977) Pathogenesis and management of uterine inertia complication abruptio placenta with consumptive coagulopathy. American Journal of Obstetrics and Gynecology, 129, 164-170.
22. Sorensen, B. & Bevan, D. (2010) A critical evaluation of cryoprecipitate for replacement of fibrinogen. British Journal of Haematology, 149, 834-43.
23. Stainsby, D., MacLennan, S., Thomas, D., Isaac, J., Hamilton, P.J. & British Committee for Standards in Haematology (2006) Guidelines in the management of massive blood loss. British Journal of Haematology, 135, 634-641.
24. Stinger, H.K., Spinella, P.C., Perkins, J.G. et al. (2008) The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. The Journal of Trauma, 64, S79-85.
25. CEMACH (2011) The eighth report of the confidential enquiries into maternal deaths in the United Kingdom (CEMACH). British Journal of Obstetrics and Gynaecology, 18, S171-S176.
26. Weinkove, R. & Ranjarajan, S. (2008) Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfusion Medicine, 18, 151-157.